Results 11 to 20 of about 122,915 (293)

Health-Related Quality of Life (HRQoL) in Sarcoidosis: Diagnosis, Management, and Health Outcomes

Diagnostics, 2021
Health-related quality of life (HRQoL), though rarely considered as a primary endpoint in clinical trials, may be the single outcome reflective of patient priorities when living with a health condition.
Lesley Ann Saketkoo, Anne-Marie Russell, Kelly Jensen, Jessica Mandizha, Jinny Tavee, Jacqui Newton, Frank Rivera, Mike Howie, Rodney Reese, Melanie Goodman, Patricia Hart, Bert Strookappe, Jolanda De Vries, Misha Rosenbach, Mary Beth Scholand, Mathew R. Lammi, Marjon Elfferich, Elyse Lower, Robert P. Baughman, Nadera Sweiss, Marc A. Judson, Marjolein Drent   +21 more
doaj   +1 more source

Inhibition of type 1 immunity with tofacitinib is associated with marked improvement in longstanding sarcoidosis

Nature Communications, 2022
Sarcoidosis is an idiopathic inflammatory disorder that is commonly treated with glucocorticoids. An imprecise understanding of the immunologic changes underlying sarcoidosis has limited therapeutic progress.
W. Damsky, Alice Wang, Daniel J. Kim, Bryan D. Young, Katelyn Singh, M. J. Murphy, Joseph A. Daccache, Abigale Clark, R. Ayasun, C. Ryu, M. McGeary, I. Odell, R. Fazzone-Chettiar, D. Pucar, R. Homer, M. Gulati, E. Miller, M. Bosenberg, R. Flavell, B. King   +19 more
semanticscholar   +1 more source

Gender differences in health-related quality of life measured by the Sarcoidosis Health Questionnaire

Scientific Reports, 2021
Sarcoidosis is granulomatous disease, which complex etiology is yet to be fully discovered. In the majority of cases its course is self-limiting. However it can have different clinical manifestations and can be debilitating condition with great impact on
Łukasz Gwadera, Adam J. Białas, Witold Górski, Mikołaj A. Iwański, Joanna Miłkowska-Dymanowska, Paweł Górski, Wojciech J. Piotrowski   +6 more
doaj   +1 more source

The Role of Echocardiography in the Contemporary Diagnosis and Prognosis of Cardiac Sarcoidosis: A Comprehensive Review

Life, 2023
Cardiac sarcoidosis (CS) is a rare inflammatory disorder characterised by the presence of non-caseating granulomas within the myocardium. Contemporary studies have revealed that 25–30% of patients with systemic sarcoidosis have cardiac involvement, with ...
Joseph Okafor, Rajdeep Khattar, Rakesh Sharma, Vasilis Kouranos   +3 more
doaj   +1 more source

Sarcoidosis Illuminations on Living During COVID-19: Patient Experiences of Diagnosis, Management, and Survival Before and During the Pandemic

Journal of Patient Experience, 2022
Background: Inspired by intense challenges encountered by patients and clinicians, we examined the experiences of living with sarcoidosis in three of the hardest impacted English-speaking cities during the early COVID-19 pandemic: London, New Orleans ...
Lesley Ann Saketkoo MD, MPH, Kelly Jensen MD, MPH, Dimitra Nikoletou PhD, MSc, Jacqui J. Newton, Frank J. Rivera BA, Mike Howie, Rodney K. Reese, Melanie Goodman BS, Patricia B. Hart MBA, Whitney Bembry MD, Adam Russell BA, Isabelle Lian MS, Matthew R. Lammi MD, MSCR, Mary Beth Scholand MD, Anne-Marie Russell PhD, APRN, ATSF   +14 more
doaj   +1 more source

Research progress on drug treament for sarcoidosis [PDF]

Xin yixue, 2023
Sarcoidosis is a systemic disease characterized by non-caseous epithelioid cell granuloma，which can involve with multiple organs，especially the lung. Sarcoidosis is characterized by diverse clinical manifestations and high incidence rate.
Luo Cheng, Wu Cong, Wang Yuguang
doaj   +1 more source

Diagnosis and Detection of Sarcoidosis. An Official American Thoracic Society Clinical Practice Guideline

American Journal of Respiratory and Critical Care Medicine, 2020
Background: The diagnosis of sarcoidosis is not standardized but is based on three major criteria: a compatible clinical presentation, finding nonnecrotizing granulomatous inflammation in one or more tissue samples, and the exclusion of alternative ...
E. Crouser, L. Maier, K. Wilson, C. Bonham, A. Morgenthau, K. Patterson, K. Patterson, E. Abston, R. Bernstein, R. Blankstein, E. Chen, D. Culver, W. Drake, M. Drent, A. Gerke, M. Ghobrial, P. Govender, N. Hamzeh, W. James, M. Judson, Liz Kellermeyer, S. Knight, L. Koth, V. Poletti, S. Raman, M. Tukey, G. Westney, R. Baughman   +27 more
semanticscholar   +1 more source

The Relationship between Tumor Development and Sarcoidosis in Aspects of Carcinogenesis before and after the Onset of Sarcoidosis

Medicina, 2022
Background and Objectives: It is still unclear whether sarcoidosis is likely to be associated with tumors. In addition, the use of an immune checkpoint inhibitor has been reported to initiate the onset of sarcoidosis.
Yoshimasa Hachisu, Yasuhiko Koga, Shu Kasama, Kyoichi Kaira, Shogo Uno, Masakiyo Yatomi, Haruka Aoki-Saito, Hiroaki Tsurumaki, Asuka Jingu, Noriaki Sunaga, Toshitaka Maeno, Takeshi Hisada   +11 more
doaj   +1 more source

Sarcoidosis lung transplantation waitlist mortality, a national registry database study

ERJ Open Research, 2023
Background The Lung Allocation Score (LAS) prioritises lung transplantation candidates, balancing waitlist mortality and post-transplant survival. The score groups sarcoidosis candidates based on mean pulmonary artery pressure: those with ≤30 mmHg ...
Derlis C. Fleitas Sosa, Shameek Gayen, Matthew Zheng, Andrew J. Gangemi, Huaqing Zhao, Victor Kim, Sameep Sehgal, Gerard J. Criner, Rohit Gupta, A. James Mamary   +9 more
doaj   +1 more source

Safety and tolerability of pirfenidone in asbestosis: a prospective multicenter study

Respiratory Research, 2022
Background Pirfenidone slows down disease progression in idiopathic pulmonary fibrosis (IPF). Recent studies suggest a treatment effect in progressive pulmonary fibrosis other than IPF.
Jelle R. Miedema, Catharina C. Moor, Marcel Veltkamp, Sara Baart, Natascha S. L. Lie, Jan C. Grutters, Marlies S. Wijsenbeek, Rémy L. M. Mostard   +7 more
doaj   +1 more source